Sage Journals: Discover world-class research

Abstract

Objectives:

This study aimed to characterize use and perceptions of cannabidiol (CBD) products.

Materials and Methods:

Participants aged 16–65 years in Canada (n=15,042) and the United States (n=30,288) completed measures on prevalence and patterns of CBD product use and perceptions of CBD oil as part of the 2019 International Cannabis Policy Study online survey.

Results:

Past 12-month CBD product use was significantly more prevalent among respondents in the United States (26.1%) than in Canada (16.2%). Consumers in the United States and Canada reported using a range of CBD products, including drops (46.3% vs. 47.3%, respectively), topicals (26.0% vs. 16.7%), edibles/foods (23.8% vs. 17.6%), vape oils (18.9% vs. 13.3%), capsules (13.3% vs. 16.7%), and dried flower (10.1% vs. 16.1%). CBD was most commonly reported for management of pain, anxiety, and depression. Over half of CBD consumers in both countries reported that CBD oil was beneficial for health.

Conclusions:

Use of CBD products is common in both the United States and Canada, primarily to manage self-reported health conditions for which there is little or no evidence of efficacy. Clearer public health messaging regarding the therapeutic effects of CBD is warranted.

Get full access to this article

View all access options for this article.

References

White

. A review of human studies assessing cannabidiol's (CBD) therapeutic actions and potential. J Clin Pharmacol. 2019; 59:923–934.

Papagianni

, Stevenson

. Cannabinoid regulation of fear and anxiety: an update. Curr Psychiatry Rep. 2019; 21:38.

Millar

, Stone

, Bellman

, et al. A systematic review of cannabidiol dosing in clinical populations. Br J Clin Pharmacol. 2019; 85:1888–1900.

Iseger

, Bossong

. A systematic review of the antipsychotic properties of cannabidiol in humans. Schizophr Res. 2015; 162:153–161.

Hindley

, Beck

, Borgan

, et al. Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis. Lancet Psychiatry. 2020; 7:344–353.

Englund

, Freeman

, Murray

, et al. Can we make cannabis safer?. Lancet Psychiatry. 2017; 4:643–648.

Hager

, Pellegrini

. CBD: the trendy cannabis compound that's blurring the law for Canadians. The Globe and Mail. 2019. Available at: https://www.theglobeandmail.com/cannabis/article-cbd-from-cannabis-it-wont-get-you-high-but-could-get-you-charged/ (accessed November 10, 2020).

Reiley

. CBD-infused food and beverages are still illegal under U.S. law. So why are they everywhere? The Washington Post. 2019. Available at: https://www.washingtonpost.com/business/2019/06/24/cbd-infused-food-beverages-are-still-illegal-under-us-law-so-why-are-they-everywhere/ (accessed November 10, 2020).

National Conference of State Legislatures. State Medical Marijuana Laws. 2020. Available at: https://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx (accessed November 11, 2020).

10.

Congressional Research Service. The 2018 Farm Bill (P.L. 115–334): summary and side-by-side comparison. 2019. Available at https://crsreports.congress.gov/product/pdf/R/R45525 (accessed November 10, 2020).

11.

LaVito

. Walgreens to sell CBD products in 1,500 stores. CNBC. 2019. Available at: https://www.cnbc.com/2019/03/27/walgreens-to-sell-cbd-products-in-some-stores.html#:~:text=Bloomberg%20%7C%20Getty%20Images-,Walgreens%20will%20sell%20CBD%20creams%2C%20patches%20and%20sprays%20in%20nearly,South%20Carolina%2C%20Illinois%20and%20Indiana (accessed November 10, 2020).

12.

Smart

, Pacula

. Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: findings from state policy evaluations. Am J Drug Alcohol Abuse. 2019; 45:644–663.

13.

ProCon.org. States with legal cannabidiol (CBD). 2020. Available at: https://medicalmarijuana.procon.org/states-with-legal-cannabidiol-cbd/ (accessed November 10, 2020).

14.

Government of Canada. Cannabis regulations (SOR/2018–2144). Cannabis Act. Controlled drugs and substances act. Food and drugs act. 2019. Available at: https://laws-lois.justice.gc.ca/eng/regulations/SOR-2018-144/FullText.html (accessed November 10, 2020).

15.

Government of Canada. Health Canada finalizes regulations for the production and sale of edible cannabis, cannabis extracts and cannabis topicals. 2019. Available at: https://canada.ca/en/health-canada/news/2019/06/health-canada-finalizes-regulations-for-the-production-and-sale-of-edible-cannabis-cannabis-extracts-and-cannabis-topicals.html (accessed November 10, 2020).

16.

Government of Canada. Health products containing cannabis or for use with cannabis: guidance for the Cannabis Act, the Food and Drugs Act, and related regulations 2020. Available at: https://canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/guidance-cannabis-act-food-and-drugs-act-related-regulations/document.html (accessed November 10, 2020).

17.

Mahamad

, Wadsworth

, Rynard

, et al. Availability, retail price, and potency of legal and illegal cannabis in Canada after recreational cannabis legalisation. Drug Alcohol Rev. 2020; 39:337–346.

18.

Ontario Cannabis Store. CBD vapes. 2020. Available at: https://ocs.ca/collections/cbd-vapes?product=4350455613260 (accessed November 10, 2020).

19.

Ontario Cannabis Store. The ABCs of CBD. 2020. Available at: https://ocs.ca/pages/cbd (accessed November 10, 2020).

20.

Bud Beaver Canada. CBD and cannabinoids. 2020. Available at: https://budbeaver.ca/collections/cbd-cannabinoids (accessed November 10, 2020).

21.

Brightfield Group. From farm to aisle: US CBD market 2019 report. 2019. Available at: https://content.brightfieldgroup.com/2019-us-cbd-market (accessed November 10, 2020).

22.

Corroon

, Phillips

. A cross-sectional study of cannabidiol users. Cannabis Cannabinoid Res. 2018; 3:152–161.

23.

Kruger

, Kruger

, Collins

. Frequent cannabis users demonstrate low knowledge of cannabinoid content and dosages. Drugs Educ Prev Policy. 2020 [Epub ahead of print]; DOI: 10.1080/09687637.2020.1752150.

24.

Kopf

, Avins

. New data show Americans are turning to CBD as a cure-all for the modern condition. Quartz. 2019. Available at: https://qz.com/1590765/survey-shows-americans-use-cbd-to-treat-anxiety-and-stress/ (accessed November 10, 2020).

25.

Jones

, Saad

. Gallup poll social series: consumption habits. Gallup News Service. 2019. Available at: http://gallup.com/file/poll/263729/190807CBDProducts.pdf (accessed November 10, 2020).

26.

Hammond

, Goodman

, Wadsworth

, et al. International cannabis policy study wave 2 survey. 2019. Available at: http://cannabisproject.ca/methods/ (accessed November 10, 2020).

27.

Hammond

, Goodman

, Wadsworth

, et al. Evaluating the impacts of cannabis legalization: the International Cannabis Policy Study. Int J Drug Policy. 2020; 77:102698.

28.

Goodman

, Hammond

. International Cannabis Policy Study: technical report—Wave 2. 2019. University of Waterloo. Available at: http://cannabisproject.ca/methods/ (accessed November 10, 2020).

29.

Battaglia

, Izrael

, Ball

. Tips and tricks for raking survey data with advanced weight trimming. SESUG Paper SD-62-2017. 2017. Available at: https://abtassociates.com/sites/default/files/files/Insights/Tools/SD_62_2017.pdf (accessed November 10, 2020).

30.

ABT Associates. Raking survey data (a.k.a. sample balancing). 2020. Available at: https://www.abtassociates.com/raking-survey-data-aka-sample-balancing (accessed November 10, 2020).

31.

Goodman

, Wadsworth

, Leos-Toro

, et al. Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets. Int J Drug Policy. 2020; 76:102658.

32.

Substance Abuse and Mental Health Services Administration (SAMHSA). 2017–2018 National Survey on Drug Use and Health: model-based prevalence estimates (50 states and the District of Columbia). 2019. Available at: https://www.samhsa.gov/data/report/2017-2018-nsduh-state-prevalence-estimates (accessed November 10, 2020).

33.

Government of Canada. Canadian Cannabis Survey 2019-summary. 2019. Available at: https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/canadian-cannabis-survey-2019-summary.html (accessed November 10, 2020).

34.

Sexton

, Cuttler

, Finnell

, et al. A cross-sectional survey of medical cannabis users: patterns of use and perceived efficacy. Cannabis Cannabinoid Res. 2016; 1:131–138.

35.

Lucas

, Baron

, Jikomes

. Medical cannabis patterns of use and substitution for opioids and other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients. Harm Reduct J. 2019; 16:9.

36.

Altemus

, Sarvaiya

, Neill Epperson

. Sex differences in anxiety and depression clinical perspectives. Front Neuroendocrinol. 2014; 35:320–330.

37.

Quinton

. Cannabis confusion pushes states to ban smokable hemp. The PEW Charitable Trusts. 2020. Available at: https://www.pewtrusts.org/en/research-and-analysis/blogs/stateline/2020/01/06/cannabis-confusion-pushes-states-to-ban-smokable-hemp (accessed November 10, 2020).

38.

Hoffenberg

EJM

, McWilliams

, Mikulich-Gilbertson

, et al. Cannabis oil use by adolescents and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2019; 68:348–352.

39.

Meier

, Dussy

, Scheurer

, et al. Cannabinoid concentrations in blood and urine after smoking cannabidiol joints. Forensic Sci Int. 2018; 291:62–67.

40.

Government of Canada. Impaired driving laws. 2019. Available at: https://justice.gc.ca/eng/cj-jp/sidl-rlcfa/ (accessed November 10, 2020).

41.

Smith

, Dunn

, Comer

. Assessing the feasibility of evaluating the legal implications of marijuana per se statutes in the criminal justice system. AAA Foundation for Traffic Safety. 2019. Available at: https://aaafoundation.org/wp-content/uploads/2019/05/MarijuanaPerSe_FinalReport_VTTI_complete.pdf (accessed November 10, 2020).

42.

Lachenmeier

, Habel

, Fischer

, et al. Are side effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?. F1000Res. 2020; 8:1394.

43.

Fahimi

, Frances

, Thomas

. A practical guide for surveys based on nonprobability samples [Webinar]. American Association for Public Opinion Research (AAPOR). 2018. Available at: https://www.aapor.org/Education-Resources/Online-Education/Webinar-Details.aspx?webinar=WEB0218 (accessed November 10, 2020).

44.

Hays

, Liu

, Kapteyn

. Use of internet panels to conduct surveys. Beh Res Methods. 2015; 47:685–690.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.15 MB

Use and Perceptions of Cannabidiol Products in Canada and in the United States

Abstract

Objectives:

Materials and Methods:

Results:

Conclusions:

Get full access to this article

References

Supplementary Material